These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 549184)

  • 21. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
    Simon GL; Klempner MS; Kasper DL; Gorbach SL
    J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence of Bacteroides fragilis in vivo.
    Onderdonk AB; Moon NE; Kasper DL; Bartlett JG
    Infect Immun; 1978 Mar; 19(3):1083-7. PubMed ID: 640723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cell-surface antigens of Bacteroides thetaiotaomicron.
    Meisel-Mikolajczyk F; Rokosz A; Kaca W
    Eur J Epidemiol; 1989 Dec; 5(4):486-96. PubMed ID: 2514115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and identification of encapsulated strains of Bacteroides fragilis.
    Kasper DL; Hayes ME; Reinap BG; Craft FO; Onderdonk AB; Polk BF
    J Infect Dis; 1977 Jul; 136(1):75-81. PubMed ID: 328787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen.
    Kasper DL; Onderdonk AB; Reinap BG; Linberg AA
    J Infect Dis; 1980 Nov; 142(5):750-6. PubMed ID: 7462689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative determination of the serum antibody response to the capsular polysaccharide of Bacteroides fragilis subspecies fragilis in women with pelvic inflammatory disease.
    Kasper DL; Eschenbach DA; Hayes ME; Holmes KK
    J Infect Dis; 1978 Jul; 138(1):74-80. PubMed ID: 98597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species specific monoclonal antibodies to Bacteroides fragilis lipopolysaccharide protect mice from severe infection.
    Brake B; Larcher C; Schulz TF; Prodinger W; Dierich MP
    Zentralbl Bakteriol; 1992 Oct; 277(3):320-8. PubMed ID: 1283090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro.
    Brubaker JO; Li Q; Tzianabos AO; Kasper DL; Finberg RW
    J Immunol; 1999 Feb; 162(4):2235-42. PubMed ID: 9973499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteroides fragilis strains express multiple capsular polysaccharides.
    Pantosti A; Tzianabos AO; Reinap BG; Onderdonk AB; Kasper DL
    J Clin Microbiol; 1993 Jul; 31(7):1850-5. PubMed ID: 8349763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenicity of piliated and encapsulated Bacteroides fragilis.
    Brook I; Coolbaugh JC; Walker RI
    Eur J Clin Microbiol; 1984 Jun; 3(3):207-9. PubMed ID: 6147247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteraemia and seeding of capsulate Bacteroides spp. and anaerobic cocci.
    Brook I
    J Med Microbiol; 1987 Feb; 23(1):61-7. PubMed ID: 3820272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of a specific bacterial antigen in urine of rats with Bacteroides fragilis infection.
    Rissing JP; Buxton TB; Harris RW; Shockley RK; Craven P; Moore WL
    J Lab Clin Med; 1983 Sep; 102(3):392-9. PubMed ID: 6886522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides.
    Weintraub A; Larsson BE; Lindberg AA
    Infect Immun; 1985 Jul; 49(1):197-201. PubMed ID: 4008048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.
    Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB
    J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The
    Parker AC; Bergonia HA; Seals NL; Baccanale CL; Rocha ER
    Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32457103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria.
    Wade BH; Kasper DL; Mandell GL
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():51-62. PubMed ID: 6643341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The humoral antibody response to Bacteroides fragilis infections in humans.
    Lindberg AA; Weintraub A; Nord CE
    Scand J Infect Dis Suppl; 1979; (19):46-51. PubMed ID: 288165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses.
    Crabb JH; Finberg R; Onderdonk AB; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S178-84. PubMed ID: 2406870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunochemical characterization of a polysaccharide antigen of Bacteroides fragilis with an IgM monoclonal antibody.
    Reid JH; Patrick S; Tabaqchali S
    J Gen Microbiol; 1987 Jan; 133(1):171-9. PubMed ID: 3309142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the antigenic composition of the fragilis group of Bacteroides.
    Elhag KM; Alkarmi TO
    J Med Microbiol; 1991 Aug; 35(2):118-22. PubMed ID: 1875392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.